Potential of bacterial vaccines in the prevention of acute otitis media

This publication has 95 references indexed in Scilit:

• Costs arising from otitis media
  Acta Paediatrica, 2007
• Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid1Presented in part at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 1995 and the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 1996.1
  Vaccine, 1999
• Serum Antibodies Specific to CD Outer Membrane Protein ofMoraxella catarrhalis, P6 Outer Membrane Protein of Non-typeableHaemophilus influenzaeand Capsular Polysaccharides ofStreptococcus pneumoniaein Children with Otitis Media with Effusion
  Acta Oto-Laryngologica, 1998
• Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae
  Gene Therapy, 1997
• Overall cost in the treatment of otitis media
  The Pediatric Infectious Disease Journal, 1997
• Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats
  APMIS, 1996
• Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization
  Vaccine, 1996
• Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants
  The Pediatric Infectious Disease Journal, 1996
• Truncated Streptococcus pneumoniae PspA Molecules Elicit Cross-Protective Immunity against Pneumococcal Challenge in Mice
  The Journal of Infectious Diseases, 1996
• Use of Pneumococcal Vaccine for Prevention of Recurrent Acute Otitis Media in Infants in Boston
  Clinical Infectious Diseases, 1981